CompletedNot applicableNCT00789971
Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification
Studying OBSOLETE: Rare inflammatory eye disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sligo General Hospital
- Principal Investigator
- Paul Mullaney, FRCOphthSligo General Hospital
- Intervention
- triamcinolone acetonide(drug)
- Enrollment
- 150 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2007 – 2008
Study locations (1)
- Sligo General Hospital, Sligo, Sligo, Ireland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00789971 on ClinicalTrials.gov